Androgen deprivation therapy and excess mortality in men with prostate cancer during the initial phase of the COVID-19 pandemic.

Two new papers that advance our understanding of the relationship between prostate cancer and diabetes…as well as the implications of treating the diabetes itself.

Supervised exercise therapy compared with no exercise therapy to reverse debilitating effects of androgen deprivation therapy in patients with prostate cancer: a systematic review and meta-analysis.

Effect of androgen deprivation therapy on cognitive functioning in men with prostate cancer: A systematic review.

Risk of cardiovascular intervention after androgen deprivation therapy in prostate cancer patients with a prior history of ischemic cardiovascular and cerebrovascular disease: A nationwide population-based cohort study.

Dietary interventions to improve body composition in men treated with androgen deprivation therapy for prostate cancer: a solution for the growing problem?

Cardiovascular Events in Men with Prostate Cancer Receiving Hormone Therapy: An Analysis of the FDA Adverse Event Reporting System (FAERS).

Androgen-deprivation therapy may reduce the risk of primary open-angle glaucoma in patients with prostate cancer: A nationwide population-based cohort study.

Hormone therapy use and the risk of acute kidney injury in patients with prostate cancer: a population-based cohort study.

Triple-arm androgen blockade for advanced prostate cancer: a review.